Concepedia
Statistics
Publications
17
Citations
691
H-Index
14
Active since
2005
Affiliations
University of Otago(Current)
Christchurch Hospital
Bristol-Myers Squibb (United States)
Biogen (United States)
The University of Texas MD Anderson Cancer Center
Sarah Harris is an author at University of Otago specializing in medicine, pharmacology, and oncology.
Publications per year
2005–2023
Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
John C. Byrd, Susan O’Brien, Ian W. Flinn et al. · Clinical Cancer Research · 2007 · 102 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
John C. Byrd, Thomas J. Kipps, Ian W. Flinn et al. · Blood · 2009 · 100 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Approach to Validating an Opsonophagocytic Assay for <i>Streptococcus pneumoniae</i>
Branda Hu, Xinhong Yu, Thomas R. Jones et al. · Clinical and Vaccine Immunology · 2005 · 80 citations · Full text
Life Sciences, Immunology, Infectious Diseases +13
Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors
Tinya J. Abrams, Anu Connor, Christie Fanton et al. · Clinical Cancer Research · 2018 · 66 citations
Medicine, Oncology, Pharmacology +15
Cardiovascular Outcomes in Young Adulthood in a Population-Based Very Low Birth Weight Cohort
Sarah Harris, Helen Bray, Richard W. Troughton et al. · The Journal of Pediatrics · 2020 · 57 citations
Medicine, Cardiology, Pediatrics +10
1–5 of 17